Teligent Pharma

Mergers and acquisitions deals consolidation
Manufacturing

Hikma shells out $45.75M, snapping up Teligent's Canadian assets

Hikma, a London-based generics maker, paid $45.75 million to snap up the Canadian assets of Teligent, which filed for bankruptcy last October.
Joseph Keenan Jan 18, 2022 10:05am
FDA Building 2

Sterility and superpotency concerns have triggered 2 recalls

Dec 8, 2021 9:55am
building

Troubled Teligent pulls lot of 'super potent' topical lidocaine

Sep 7, 2021 11:39am
lady justice

States file 3rd generics price-fixing suit against 26 firms

Jun 10, 2020 1:54pm
building

FDA faults U.S. plant for releasing out-of-spec eczema treatment

Dec 12, 2019 9:40am